Select Page

Global Electronic Pill Industry research report offers granulated yet in-depth analysis of revenue share, market segments, revenue estimates and various regions across the globe.

Market Scenario

The growing prevalence of gastrointestinal diseases, increasing unhealthy food consumption, increase in research and development activities, growing government reimbursement policies, rising geriatric population, increased need for rapid diagnostics, and adoption of advanced technologies are the key factors for the electronic pill market to grow. However, factors such as bowel obstruction, lack of awareness, capsule retention and high costs are expected to restrict the market growth during the forecast period.

The Global Electronic Pill Market is expected to reach an approximate CAGR of 15% during the forecast period.

The electronic pill is an ingestible capsule that is embedded with sensors and camera. After ingesting the pill, the pill captures several images per second of the gastrointestinal tract which is received by the connected recording device. It is a monitoring system used to monitor temperature, pH, conductivity and dissolved oxygen. Electronic Pills are used for diagnostics of various gastrointestinal tract diseases like colon cancer, colon polyps, gastrointestinal bleeding and other infectious diseases. The increase in preference of non-invasive methods for diagnostics is driving the growth of the market. Moreover, the rising geriatric population, increasing prevalence of gastrointestinal diseases like colorectal cancer, changing lifestyle, increasing unhealthy eating habits, controlled drug delivery and better way of endoscopy procedures are major factors influencing the growth of the market.

Global Electronic Pill Market, by Key Players

  • CapsoVision, Inc. (US)
  • Given Imaging Ltd. (Israel)
  • Medimetrics (Mexico)
  • Bio-Images Drug Delivery BDD LTD (UK)
  • Proteus Digital Health (US)
  • Olympus Corporation
  • Medtronic
  • Medisafe
  • JINSHAN Science & Technology
  • INTROMEDIC

Segmentation

On the basis of region, the global Electronic Pill market is segmented into the Americas, Europe, Asia Pacific, and the Middle East and Africa.

The Americas is sub-segmented into North America and South America. The North American region is further segmented into the US and Canada. The European region is divided into two, namely, Western Europe and Eastern Europe. Western Europe is further classified into Germany, Italy, France, the U.K., Spain, and the rest of Western Europe. The Asia Pacific region is sub-segmented into Japan, China, India, Australia, the Republic of Korea, and the rest of Asia Pacific. The Middle Eastern and African region is sub-segmented into the United Arab Emirates, Saudi Arabia, Oman, Kuwait, Qatar, and the rest of the Middle East and Africa.

The global electronic pill market is segmented on the basis of Application, Target area, Parts and end user. The electronic pill market, by application, is sub-segmented into Capsule Endoscopy, Drug Delivery, and Patient Monitoring. Target area category includes Oesophagus, Stomach, Small Intestine, and large intestine.

By parts, the market is categorized into biocompatible capsule encasing microsensors, Control chip, Radio transmitter and Power source. On the basis of end-user, the market is segmented into Hospitals, Diagnostic centers, Clinical Research Organizations and Medical Centers.

Regional Market Summary

The Electronic Pill market is dominated by North America owing to rising prevalence of gastrointestinal disorders and high R&D investments within this region stimulate market growth. According to the US Investments in Medical and Health Research and Development in 2016, the United States invested total $171.8 billion in medical and health R&D and the investment increased by 20.6% from 2013 to 2016. Also, the rising adoption of technologically advanced systems for early diagnosis of gastrointestinal disorders influences the market growth in this region.

It is estimated that Europe stood second in the global Electronic Pill market. The increasing prevalence of gastric cancer is driving the growth of this market in Europe. According to the Cancer Research UK in 2015, 6740 new cases of stomach cancer in the U.K and is among the most common prevalent cancer. Thus, increasing prevalence of gastric cancer in Europe drives the market growth. Furthermore, the rapidly growing healthcare sector in Europe is expected to boost the market in this region.

Asia Pacific was projected to be the fastest growing region for the global Electronic Pill market. Key factors such as rising geriatric population, growing patient pool, high incidence of gastrointestinal diseases and developing healthcare infrastructure drive the market in this region. According to the Asian Development Bank (ADB), the geriatric population in Asia is expected to reach 923 million by 2050. This provides favorable backgrounds for the market to grow.

The Middle East and Africa holds the least share in the global Electronic Pill market due to the presence of stringent government policies and poor economic growth. However, growing awareness and increasing investment by private market players in this region can boost the market growth.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/electronic-pill-market-6204